Received for publication, January 22, 2002, and in revised form, April 12, 2002
Poly(ADP-ribose) polymerase-1 (PARP-1) is
activated by DNA strand breaks during cellular genotoxic stress
response and catalyzes poly(ADP-ribosyl)ation of acceptor proteins.
These acceptor proteins include those involved in modulation of
chromatin structure, DNA synthesis, DNA repair, transcription, and cell
cycle control. Thus, PARP-1 is believed to play a pivotal role in
maintaining genome integrity through modulation of protein-protein and
protein-DNA interactions. We previously described the association of
PARP-1 with normal mammalian centromeres and human neocentromeres by affinity purification and immunofluorescence. Here we investigated the
interaction of this protein with, and poly(ADP-ribosyl)ation of, three
constitutive centromere proteins, Cenpa, Cenpb, and Cenpc, and a
spindle checkpoint protein, Bub3. Immunoprecipitation and Western blot
analyses demonstrate that Cenpa, Cenpb, and Bub3, but not Cenpc,
interacted with PARP-1, and are poly(ADP-ribosyl)ated following
induction of DNA damage. The results suggest a role of PARP-1 in
centromere assembly/disassembly and checkpoint control. Demonstration
of PARP-1-binding and poly(ADP-ribosyl)ation in three of the four
proteins tested further suggests that many more centromere proteins may
behave similarly and implicates PARP-1 as an important regulator of
diverse centromere function.
 |
INTRODUCTION |
Centromeres form the primary constriction of mammalian
metaphase chromosomes. They are the sites of kinetochore formation and
microtubule attachment and mediate the faithful division of sister
chromatids during mitotic cell division (1). Electron microscopy
reveals kinetochore as a trilaminar structure that can be delineated
into three separate domains, the inner, middle, and outer zones (2-5).
A host of centromere-specific proteins reside at one or another of
these zones to provide essential functions such as structural
organization, microtubule binding, motor movement, cytokinesis, and
checkpoint control (1, 6-12). These proteins can be generally
classified as constitutive or transient proteins. Constitutive proteins
(CENP-A, CENP-B, CENP-C, CENP-G, and CENP-H) reside at the centromere
at all stages of the cell cycle, whereas the transient proteins
(e.g. CENP-E, CENP-F, INCENP, survivin, MCAK, ZWINT-1, ZW10,
MAD-1, MAD-2, BUB1, BUBR1, and BUB3) associate with the centromere
during specific stages of the cell cycle. Constitutive proteins CENP-A,
CENP-C, and CENP-H are essential for correct kinetochore assembly and
function as evidenced by a lethal phenotype in gene knockout and
antibody/RNA inhibition studies in mouse, worm, and chicken DT40 cells
(13-21), whereas CENP-B appears to be functionally redundant for
centromere activity (22-24). Numerous gene knockout and inhibition
studies have demonstrated that many of the transient proteins have
essential roles in normal mitotic functions, such as INCENP, survivin,
CENP-E, BUB3, and MAD2 (25-30).
Poly(ADP-ribose) polymerase-1
(PARP-1)1 is a
multifunctional enzyme that catalyzes the formation of poly(ADP-ribose)
polymers on acceptor proteins involved in the maintenance of chromatin structure and DNA repair (31-37). The addition of poly(ADP-ribose) units makes the acceptor proteins more negatively charged, thus altering their structure, function, and binding properties to DNA
(38-40). Poly(ADP-ribosyl)ation of acceptor proteins signals DNA
lesion to downstream effectors involved in coordinating the recruitment
of DNA repair complexes to the site of DNA damage (41-48). PARP-1 is
also thought to play a role in the maintenance of genomic stability
under genotoxic stress. Cells from PARP-1 knockout mice show increased
chromosomal breakages, high genomic instability, and decreased ability
to repair DNA damage (49-54). The continued presence of
poly(ADP-ribosyl)ation in cells devoid of PARP-1 has been attributed to
the activities of other members of the PARP family, of which five have
now been identified (55-61).
We have previously shown that PARP-1 accumulates at active mammalian
centromeres (including neocentromeres) on metaphase chromosomes (62).
As a first step toward deciphering the possible functions of PARP-1 at
the centromere, we investigated the association of PARP-1 with several
centromere-specific proteins. By co-immunoprecipitation, we have
identified CENP-A, CENP-B, and the spindle checkpoint protein, BUB3,
but not CENP-C, as binding partners of PARP-1 and have demonstrated
poly(ADP-ribosyl)ation of CENP-A, CENP-B, and BUB3 upon induction of
DNA damage in cells.
 |
MATERIALS AND METHODS |
Cell Cultures and Preparation of Nuclear Extracts--
All cell
lines, including wild-type mouse embryonic stem (ES) cells W9.5,
ES-GFP, and ES-Cenpa:GFP, were grown in ES medium supplemented with
10% fetal calf serum (Trace Biosciences), leukemia inhibitory factor
(ESGROTM, Chemicon International), and
-mercaptoethanol in the
presence of 5% CO2 at 37 °C. The ES-GFP cell line was
generated by electroporation of ES cells with plasmid pEGFP-C1
(Clonetech), which contained a neomycin-resistant gene and a gene
expressing green fluorescent protein (GFP) using a Gene Pulsar
transfection apparatus (Bio-Rad). Cells were allowed to grow for
24 h before the addition of 250 µg/ml G418 (Invitrogen)
for selection of clones. ES-Cenpa:GFP was a heterozygous ES cell line
containing one copy of the mouse Cenpa-GFP fusion protein. This cell
line was generated using a targeted knock-in strategy, where GFP was
placed at the C terminus of
Cenpa.2
For the preparation of nuclear protein extracts, 107 cells
were harvested and lysed in ice-cold lysis buffer as previously described (24).
Irradiation of ES Cells--
Exponentially dividing ES cells
were harvested and subjected to 10 or 30 Gy of
irradiation at room
temperature in an irradiator using cobalt 60 as a source at a rate of
30 Gy/1.2 min over a period of 0.4-1.2 min.
Antisera--
Antisera used in this study included mouse
monoclonal anti-PARP-1 antibody C2-10 (Trevigen, Gaithersburg, MD),
mouse monoclonal anti-poly(ADP-ribose) antibody (PAR) (Trevigen,
Gaithersburg, MD), goat polyclonal anti-GFP antibody (Rockland,
Gilbertsville, PA), mouse monoclonal Cenpb 2D-7 (2), rabbit polyclonal
anti-Cenpc antiserum (63), and rabbit polyclonal anti-Bub3 antiserum
(64). Horseradish peroxidase-conjugated secondary antibodies were
purchased from Jackson Immunoresearch Laboratories (West Grove, PA).
Immunoprecipitation--
Nuclear protein extracts (500 µl)
were incubated with 5 µg of antisera overnight at 4 °C with gentle
agitation. The extract/antibody mixtures were then incubated with 125 µl of 50% protein G-Sepharose resuspended in incubation buffer (50 mM NaCl, 20 mM Tris, 5 mM EDTA, 0.1 mM phenylmethylsulfonyl fluoride) containing a mixture of protease inhibitors (CompleteTM; Roche Molecular
Biochemicals) for 3 h at room temperature with constant agitation.
The Sepharose beads were then pelleted by centrifugation and washed in
immunoprecipitation wash buffer (50 mM Tris, 10 mM EDTA, and 150 mM NaCl), prior to elution
with incubation buffer containing 1% SDS.
Western Blot Analysis--
Protein samples were subjected to
PAGE on 10% gel and were transferred to Hybond C (Amersham
Biosciences) by standard Western blotting. Blots were incubated with
the relevant primary antisera at dilutions recommended by the
manufacturers. After washing in phosphate-buffered saline containing
0.1% Tween 20, blots were incubated with relevant horseradish
peroxidase-conjugated secondary antisera and developed using a
chemiluminescence detection kit (Amersham Biosciences).
 |
RESULTS |
Cenpa Interacts with PARP-1 and Is Poly(ADP-ribosyl)ated--
To
study the physical interaction of PARP-1 with centromere protein Cenpa,
anti-PARP-1 antibody was used to immunoprecipitate the Cenpa:GFP fusion
protein from nuclear cell extract prepared from the ES-Cenpa:GFP cell
line (see "Materials and Methods"), followed by immunoblotting with
anti-GFP antiserum. In a separate study,2 the Cenpa:GFP
fusion protein has been shown to localize specifically to mouse
centromeres and provide normal centromere function in the ES-Cenpa:GFP
heterozygous cell line. A parental ES cell line W9.5 and an ES-GFP cell
line overexpressing GFP were included as controls in the
immunoprecipitation assays. A band of 43 kDa corresponding to the
Cenpa:GFP fusion protein was observed when the ES-Cenpa:GFP nuclear
extract, but not extracts from the W9.5 or ES-GFP cells, was used for
immunoprecipitation (Fig. 1A).
To confirm the specificity of this interaction, anti-GFP antibody was
used to immunoprecipitate nuclear extracts from the same cell lines,
followed by immunoblotting with anti-PARP-1 antibody. Two bands of
~113 and 89 kDa, corresponding to the full-length and apoptotic
fragments of PARP-1, were detected in the ES-Cenpa:GFP extract alone
(Fig. 1B). These results therefore indicate that PARP-1
interacts with Cenpa.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 1.
Western blot analysis of PARP-1 binding and
poly(ADP-ribosyl)ation of Cenpa. A, nuclear extracts
from ES-Cenpa:GFP fusion cell line, ES:GFP cell line, and control
parental ES cell line W9.5 were immunoprecipitated using anti-PARP-1
antibody, Western blotted, and probed with a goat anti-GFP antibody.
The solid arrow indicates the 43-kDa band
corresponding to the Cenpa:GFP fusion product, seen only in the
Cenpa:GFP cell line. The 27-kDa immunoglobulin light chain
(open arrow) is seen in all three lanes.
B, immunoprecipitation of W9.5 ES cell line, ES:GFP cell
line, and ES-Cenpa:GFP cell line using anti-GFP antibody and probed
with anti-PARP-1 antibody. Bands corresponding to full-length PARP-1
(large arrow) and its apoptotic fragment
(small arrow) are seen only in the ES-Cenpa:GFP
cell extract. C, immunoprecipitation of the Cenpa:GFP cell
line irradiated with 10-Gy irradiation (left-hand lane) or
no irradiation (0 Gy) using anti-PAR antibody and probed with anti-GFP
antibody. A faint band corresponding to Cenpa:GFP (arrow) is
detectable following irradiation but absent in nonirradiated cells. The
open arrow indicates light chain of IgG.
D, immunoprecipitation of cell lines treated with 10-Gy
irradiation for the W9.5 cell line, ES-GFP cell line, and ES-Cenpa:GFP
cell line using anti-PAR antibody or the ES-Cenpa:GFP cell line using
anti-GFP antibody (right-hand lane). Immunoblotting was
performed using anti-GFP antibody. The 43-kDa Cenpa:GFP protein band
(solid arrow) is strongly present as expected in
the anti-GFP immunoprecipitate and faintly in the anti-PAR
immunoprecipitate of the ES-Cenpa:GFP cell line and is undetectable in
both the control ES and ES:GFP cell lines. The open
arrow indicates IgG light chain. E, the
ES-Cenpa:GFP cell line was either not irradiated and immunoprecipitated
using anti-PAR antibody or was irradiated at 30 Gy, followed by
immunoprecipitation using anti-PAR or anti-GFP antibody and probed with
anti-GFP antibody. The Cenpa:GFP band (solid
arrow) is seen in both of the irradiated samples. The
open arrow indicates IgG light chain.
|
|
Sequence analysis of Cenpa revealed the presence of a consensus motif
for poly(ADP-ribose) or PAR-binding domain at the C terminus of the
protein, a region also showing high homology to histone H3 (65) (Fig.
2). We directly investigated the
poly(ADP-ribosyl)ation status of Cenpa using anti-PAR antibody in
immunoprecipitation experiments. The results indicated no detectable
levels of poly(ADP-ribosyl)ation on Cenpa in normal cells (Fig. 1,
C and E; 0 Gy).

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 2.
Presence of potential poly(ADP-ribose)
binding sites in mouse centromere proteins Cenpa, Cenpb, and Bub3.
The consensus PAR binding motif is shown in boldface
type and starts at the N terminus with one or more basic
amino acid residues Lys or Arg, followed by interspersion of basic
(b, underlined) and hydrophobic (h,
asterisk) residues, where x denotes a
nonconsensus amino acid (69). Sequences from Cenpa, Cenpb, and Bub3
show similar amino acid distribution patterns (in boldface
type) to the consensus PAR binding motif, in that basic
residues (Lys/Arg (K/R), underlined)
at the N-terminal position are followed by downstream basic residues
(Lys/Arg/His (K/R/H), underlined) interspersed
with hydrophobic residues (ACGVILMFYW, marked with an
asterisk). The numbers show the N-terminal amino
acid positions of the peptides for Mus musculus Cenpa,
Cenpb, and Bub3 (NCBI accession numbers O35216, P27790, and Q9WVA3,
respectively).
|
|
We next investigated the poly(ADP ribosyl)ation status of Cenpa
following the induction of DNA damage. W9.5, ES-GFP, and ES-Cenpa:GFP cells were irradiated with either 10 Gy (Fig. 1, C and
D) or 30 Gy (Fig. 1E) of
radiation followed
by immediate preparation of nuclear extracts. These were subjected to
immunoprecipitation with anti-PAR antibody and immunoblotting with
anti-GFP antibody. As shown in Fig. 1, C and D, a
low but reproducibly detectable level of poly(ADP-ribosyl)ation of the
Cenpa:GFP protein was observed following irradiation at 10 Gy. The
level of poly(ADP-ribosyl)ation of the Cenpa:GFP protein increased
noticeably following irradiation at 30 Gy (Fig. 1E). These
results indicate that Cenpa is significantly poly(ADP-ribosyl)ated
following high dose irradiation.
Cenpb Interacts with PARP-1 and Is
Poly(ADP-ribosyl)ated--
Anti-PARP-1 and anti-Cenpb antibodies were
used to immunoprecipitate nuclear extracts from W9.5 cells, followed by
immunoblotting with anti-Cenpb antibody. A band of 80-kDa corresponding
to Cenpb was detected in immunoprecipitates using both of the primary
antibodies, suggesting an interaction between PARP-1 and Cenpb (Fig.
3A). This result was confirmed
by performing the reverse experiment in which the anti-PARP-1 and
anti-Cenpb immunoprecipitates were immunoblotted with anti-PARP-1
antibody. The results indicated the expected detection of the 113-kDa
full-length PARP-1 and 89-kDa apoptotic fragment in both of the samples
(Fig. 3B).

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 3.
Western blot analysis of PARP-1 binding and
poly(ADP-ribosyl)ation of Cenpb. A, Nuclear extracts
from wild-type ES cell line W9.5 were immunoprecipitated with
anti-PARP-1 or anti-Cenpb antibody and probed with anti-Cenpb antibody.
The 80-kDa band (solid arrow) corresponding to
Cenpb is seen in both immunoprecipitates. The open
arrow shows IgG heavy chain. B, as A
except probed with anti-PARP-1 antibody. Bands corresponding to the
full-length (large arrow) and apoptotic
(small arrow) fragment of PARP-1 are seen in both
lanes. C, immunoprecipitates obtained using anti-PAR
antibody on W9.5 cells irradiated with 10 Gy or nonirradiated (0 Gy)
and probed with anti-Cenpb antibody. The Cenpb band (arrow)
is seen in the irradiated cell line only. The large and
small open arrows represent heavy and
light chains of IgG, respectively. D, 10-Gy -irradiated
W9.5 cells immunoprecipitated with anti-PAR or anti-Cenpb antibody and
probed with anti-Cenpb antibody. The Cenpb band
(arrow) is clearly seen in both lanes.
|
|
Sequence analysis also revealed a possible PAR consensus domain in
Cenpb (Fig. 2). Direct detection of poly(ADP-ribose) residues in normal
W9.5 cells gave a negative result indicating an absence of significant
poly(ADP-ribosyl)ation of this protein under normal conditions (Fig.
3C, 0 Gy). When the cells were irradiated at 10 Gy before
immunoprecipitation with either anti-PAR or anti-Cenpb antibody and
immunoblotted with anti-Cenpb antibody, Cenpb was clearly detected in
both of the immunoprecipitates (Fig. 3, C and D),
indicating that Cenpb was poly(ADP-ribosyl)ated following 10 Gy of
-radiation.
Cenpc neither Interacts with PARP-1 nor Becomes
Poly(ADP-ribosyl)ated--
Nuclear extracts from W9.5 cells
immunoprecipitated with either anti-PARP-1 or anti-Cenpc antibody were
subjected to Western blotting with either anti-PARP-1 antibody (Fig.
4A) or anti-Cenpc antibody
(Fig. 4B). Both the 113-kDa full-length PARP-1 and the 89-kDa apoptotic fragment were present when anti-PARP-1 antibody was
used in the immunoprecipitation but were absent when anti-Cenpc was
used instead (Fig. 4A). Similarly, in the reverse
experiment, the 140-kDa Cenpc band was not detected in the anti-PARP-1
immunoprecipitate but was observed in the anti-Cenpc immunoprecipitate
(Fig. 4B). Analysis of poly(ADP-ribosyl)ation status further
indicated that Cenpc was not immunoprecipitated by anti-PAR antibody in
nuclear extracts from both the nonirradiated ES cells (Fig.
4C; 0 Gy) or cells irradiated with either 10 Gy (Fig. 4,
C and D) or 30 Gy (data not shown). These
combined results suggest that Cenpc does not interact with PARP-1 and
is not poly(ADP-ribosyl)ated at detectable levels even following major
DNA damage. In support of the latter conclusion, sequence analysis of
Cenpc failed to show the presence of a consensus PAR-binding
domain.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 4.
Western blot analysis of PARP-1 binding and
poly(ADP-ribosyl)ation of Cenpc. A, nuclear extracts
from wild-type W9.5 ES cells were immunoprecipitated with anti-Cenpc or
anti-PARP-1 antibody and probed with anti-PARP-1 antibody. Bands
corresponding to the full-length (large solid
arrow) and apoptotic (small solid
arrow) fragment of PARP-1 are seen in anti-PARP-1 but not
anti-Cenpc immunoprecipitate. B, W9.5 immunoprecipitated
with anti-Cenpc or anti-PARP-1 antibody and probed with
anti-Cenpc antibody. The band corresponding to Cenpc at 140 kDa
(solid arrow) is present only in the
Cenpc-immunoprecipitated sample. C, immunoprecipitates
obtained using anti-PAR antibody on W9.5 cells irradiated with 10 Gy or
nonirradiated (0 Gy) and probed with anti-Cenpc antibody. The band
corresponding to Cenpc is undetectable in both lanes. D,
10-Gy -irradiated W9.5 cells immunoprecipitated with anti-Cenpc or
anti-PAR antibody and probed with anti-Cenpc antibody. The Cenpc
band (arrow) is seen in the Cenpc-immunoprecipitated sample
but not in the PAR immunoprecipitate. The large
and small open arrows show
heavy and light chains of IgG, respectively.
|
|
Bub3 Interacts with PARP-1 and Is Poly(ADP-ribosyl)ated--
Bub3
is a mitotic checkpoint protein that has previously been shown to
accumulate at the centromere transiently (66). We were interested in
determining the association between PARP-1 and Bub3. When nuclear
extracts from W9.5 cells were immunoprecipitated with anti-PARP-1 or
anti-Bub3 antibody and probed with anti-Bub3 antibody, a band of 40 kDa
corresponding to the Bub3 protein was detected in both of the
immunoprecipitates (Fig. 5A).
In the reverse experiment, where the same two immunoprecipitates were
Western blotted and probed with anti-PARP-1 antibody, the bands
corresponding to the full-length and apoptotic forms of PARP-1 were
detected (Fig. 5B). These results therefore demonstrate a
physical interaction between PARP-1 and Bub3.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 5.
Western blot analysis of PARP-1 binding and
poly(ADP-ribosyl)ation of Bub3. A, nuclear extracts
from wild-type ES cell line W9.5 were immunoprecipitated with
anti-PARP-1 or anti-Bub3 antibody and probed with anti-Bub3 antibody.
The 40-kDa band (solid arrow) corresponding to
Bub3 is seen in both immunoprecipitates. The open
arrow shows IgG light chain. B, as in
A, except probed with anti-PARP-1 antibody. Bands
corresponding to the full-length (large arrow)
and apoptotic (small arrow) fragment of PARP-1
are seen in both lanes. C, 10-Gy -irradiated W9.5 cells,
non- -irradiated W9.5 cells (0 Gy) immunoprecipitated with anti-PAR
antibody and probed with anti-Bub3 antibody. The band
corresponding to Bub3 is present only in the irradiated cells. The
light chain of IgG (open arrow) is seen in both
lanes.
|
|
As with Cenpa and Cenpb, sequence analysis of Bub3 showed the presence
of hydrophobic amino acids interspersed with basic amino acids, with an
accumulation of basic residues at the N-terminal side of this motif,
suggesting the possible presence of a PAR consensus domain (Fig. 2).
Use of anti-PAR antibody in immunoprecipitation and Western blot
analysis similarly detected no measurable levels of
poly(ADP-ribosyl)ation in nonirradiated W9.5 cells (Fig. 5C, 0 Gy). Following 10 Gy of irradiation and upon immunoprecipitation with
anti-PAR antibody and immunoblotting with anti-Bub3 antibody, a protein
band of 40 kDa corresponding to Bub3 was detected (Fig. 5C),
indicating that the Bub3 protein is poly(ADP-ribosyl)ated.
 |
DISCUSSION |
The post-translational modification of centromere-associated
proteins is now widely accepted as a mechanism for regulating kinetochore assembly and centromere activity. Phosphorylation of
several proteins, including CENP-A (67), CENP-E (68), 3F3/2 epitope
(69), and topoisomerase IIA (70), has been reported, and protein
kinases, including BUBR1, MPS1, aurora, and polo-like kinases,
associate directly with the mammalian centromere structure (71-74).
Farnesylation (post-translational modification of proteins by the
addition of isoprenoids) of CENP-E and CENP-F has recently been
reported and has been shown to be essential for the correct attachment
of centromeres to the mitotic spindle (75). Ubiquitination of
centromere-associated proteins also plays a pivotal role in the
progression from metaphase to anaphase (76).
Poly(ADP-ribosyl)ation of proteins by PARP-1 is a conserved
post-translational modification implicated in DNA repair, apoptosis, regulation of transcription, anti-recombination, scaffold attachment, and modulation of chromatin structure (33, 45, 47, 77-81). We have
previously demonstrated the association of PARP-1 with mammalian
centromeric DNA and active centromeres, providing circumstantial evidence for PARP-1 function at the centromere (62). In the present
study, we show that PARP-1 interacts directly with Cenpa, Cenpb, and
Bub3 under normal conditions. We further demonstrate that whereas no
significant poly(ADP-ribosyl)ation of these proteins is measurable in
unchallenged cells, all three proteins undergo poly(ADP-ribosyl)ation
upon DNA damage induced by
-irradiation. In contrast, Cenpc does not
appear to either interact with PARP-1 or undergo poly(ADP-ribosyl)ation
with or without induction of DNA damage. Given that 3 of 4 proteins
tested proved to be substrates for PARP-1 binding and
poly(ADP-ribosyl)ation and that in excess of 40 proteins have now been
shown to associate with the mammalian centromere (1, 7-10, 63, 64,
82), it is likely that other similarly behaving proteins have yet to be
identified. This together with the fact that poly(ADP-ribosyl)ation of
proteins generally changes activities or functions of these proteins
suggests that PARP-1 is likely to be involved in modulating many
different aspects of centromere behavior, including kinetochore
assembly/disassembly (e.g. by Cenpa and Cenpb) and spindle
checkpoint control (e.g. by Bub3).
CENP-A replaces histone H3 in at least a subset of centromeric
nucleosomes (83, 84). It is present at all active centromeres and
neocentromeres (64, 85) and plays an essential role in the targeting of
Cenpc to the centromere (19, 86). CENP-A is thus critical for the
correct functioning of all centromeres. Although an interaction between
PARP-1 and Cenpa is seen in the absence of DNA damage, a significant
level of poly(ADP-ribosyl)ation of Cenpa is detected only after high
doses of irradiation. This suggests that the site of
poly(ADP-ribosyl)ation on Cenpa may be inaccessible or remain dormant
in centromeric nucleosomes in the absence of an extreme assault. We
detected a consensus poly(ADP-ribosyl)ation site within the histone
fold domain of Cenpa, which is a conserved region between Cenpa and
histone H3. In noncentromeric nucleosomes, this region on histone H3 is
located deep within the final nucleosomal structure (87). If a similar
positioning occurs in the centromeric nucleosomes with Cenpa, this may
prevent access to poly(ADP-ribosyl)ation.
The discovery of PARP-1 binding and poly(ADP-ribosyl)ation of Cenpb is
interesting given that a functional role of this protein at the
centromere has not been clearly identified. CENP-B binds to a highly
conserved 17-bp "CENP-B box" motif located in a subset of
centromeric satellites and has been proposed to have a role in the
higher order organization of these satellite repeats (88, 89). This
protein is not detected on some functional centromeres (including
neocentromeres), and its complete absence such as in Cenpb
null mice does not disrupt normal centromere function (22-24, 64, 90).
It is possible, however, that Cenpb may be replaced by a functional
homologue (91) in its absence.
Following poly(ADP-ribosyl)ation, the negatively charged ADP-ribose
polymers generally render acceptor proteins incapable of DNA binding
(32, 45, 81, 92-95). A host of chromatin-associated proteins,
including all of the normal histone subunits, topoisomerase I and II,
high mobility group proteins, transcription factors, DNA synthesome
complex proteins like DNA ligase and DNA polymerase
and
, and
others, are known to undergo this modification (45, 81). Such a
modification of chromatin-associated proteins results in "opening
up" of the chromatin to allow access to the DNA (95). The detection
of poly(ADP-ribosyl)ation in two constitutive centromere proteins,
Cenpa and Cenpb, following radiation insult suggests a possible primary
and/or secondary mechanism for the decondensation of the highly compact
chromatin structures of the centromere for DNA repair. It is possible
that such a role is also maintained under normal physiological
conditions to provide the cells with a mechanism for dealing with the
small amounts of DNA damage caused by normal DNA processes or exposure
to DNA-destabilizing agents such as free oxygen radicals and UV
radiation (42, 81, 96-101).
Bub3 undergoes a transient association with centromeres prior to the
commencement of anaphase and is involved in the mitotic spindle
checkpoint function until all chromosomes are correctly aligned at the
metaphase plate (102). We have identified Bub3 as a substrate for
poly(ADP-ribosyl)ation. This modification may affect the interaction of
this protein with BUB1 and BUBR1 (103, 104), thereby altering the
functioning of the spindle checkpoint and anaphase progression. It is
interesting to speculate that poly(ADP-ribosyl)ation of Bub3 might
signal kinetochore damage to the spindle checkpoint. Alternatively,
during DNA repair, when the kinetochore is disassembled,
poly(ADP-ribosyl)ation may keep the mitotic checkpoint suppressed.
This study represents a first step toward delineating the role of
PARP-1 in centromere function. The demonstration of
poly(ADP-ribosyl)ation as a possible regulator of both constitutive
kinetochore proteins and those involved in spindle checkpoint control
adds another level of complexity to the mechanisms underlying
centromere assembly and function. Further studies should determine the
poly(ADP-ribosyl)ation status of other known centromere proteins. The
absence of any drastic centromeric phenotype in PARP-1 null mice
(51-54, 105-108) suggests some functional redundancy of PARP-1 at the
centromere. It will be interesting to investigate the binding behavior
of other members of the PARP family toward the centromere and its many proteins.
The abbreviations used are:
PARP, poly(ADP-ribose) polymerase;
PAR, poly(ADP-ribose);
GFP, green
fluorescent protein;
ES, embryonic stem;
Gy, gray(s).
| 1.
|
Choo, K. H. A.
(1997)
The Centromere
, Oxford University Press, Oxford
|
| 2.
|
Earnshaw, W. C.,
Machlin, P. S.,
Bordwell, B. J.,
Rothfield, N. F.,
and Cleveland, D. W.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
84,
4979-4983[Abstract/Free Full Text]
|
| 3.
|
Cooke, C. A.,
Bernat, R. L.,
and Earnshaw, W. C.
(1990)
J. Cell Biol.
110,
1475-1488[Abstract/Free Full Text]
|
| 4.
|
Cooke, C. A.,
Heck, M. M.,
and Earnshaw, W. C.
(1987)
J. Cell Biol.
105,
2053-2067[Abstract/Free Full Text]
|
| 5.
|
Cooke, C. A.,
Schaar, B.,
Yen, T. J.,
and Earnshaw, W. C.
(1997)
Chromosoma
106,
446-455[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Allshire, R.,
and Pidoux, A.
(2001)
Curr. Biol.
11,
454
|
| 7.
|
Dobie, K. W.,
Hari, K. L.,
Maggert, K. A.,
and Karpen, G. H.
(1999)
Curr. Opin. Genet. Dev.
9,
206-217[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Craig, J. M.,
Earnshaw, W. C.,
and Vagnarelli, P.
(1999)
Exp. Cell Res.
246,
249-262[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Kitagawa, K.,
and Hieter, P.
(2001)
Nat. Rev. Mol. Cell. Biol.
2,
678-687[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Pidoux, A. L.,
and Allshire, R. C.
(2000)
Curr. Opin. Cell Biol.
12,
308-319[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Rattner, J. B.,
Kingwell, B. G.,
and Fritzler, M. J.
(1988)
Chromosoma
96,
360-367[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Sullivan, B. A.,
Blower, M. D.,
and Karpen, G. H.
(2001)
Nat. Rev. Genet.
2,
584-596[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Blower, M. D.,
and Karpen, G. H.
(2001)
Nat. Cell. Biol.
3,
730-739[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Fukagawa, T.,
and Brown, W. R.
(1997)
Hum. Mol. Genet.
6,
2301-2308[Abstract/Free Full Text]
|
| 15.
|
Fukagawa, T.,
Pendon, C.,
Morris, J.,
and Brown, W.
(1999)
EMBO J.
18,
4196-4209[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Fukagawa, T.,
Regnier, V.,
and Ikemura, T.
(2001)
Nucleic Acids Res.
29,
3796-3803[Abstract/Free Full Text]
|
| 17.
|
Fukagawa, T.,
Mikami, Y.,
Nishihashi, A.,
Regnier, V.,
Haraguchi, T.,
Hiraoka, Y.,
Sugata, N.,
Todokoro, K.,
Brown, W.,
and Ikemura, T.
(2001)
EMBO J.
20,
4603-4617[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Figueroa, J.,
Saffrich, R.,
Ansorge, W.,
and Valdivia, M.
(1998)
Chromosoma
107,
397-405[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Howman, E. V.,
Fowler, K. J.,
Newson, A. J.,
Redward, S.,
MacDonald, A. C.,
Kalitsis, P.,
and Choo, K. H. A.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
1148-1153[Abstract/Free Full Text]
|
| 20.
|
Kalitsis, P.,
Fowler, K. J.,
Earle, E.,
Hill, J.,
and Choo, K. H. A.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
1136-1141[Abstract/Free Full Text]
|
| 21.
|
Oegema, K.,
Desai, A.,
Rybina, S.,
Kirkham, M.,
and Hyman, A. A.
(2001)
J. Cell Biol.
153,
1209-1226[Abstract/Free Full Text]
|
| 22.
|
Perez-Castro, A. V.,
Shamanski, F. L.,
Meneses, J. J.,
Lovato, T. L.,
Vogel, K. G.,
Moyzis, R. K.,
and Pedersen, R.
(1998)
Dev. Biol.
201,
135-143[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Kapoor, M.,
Montes de Oca Luna, R.,
Liu, G.,
Lozano, G.,
Cummings, C.,
Mancini, M.,
Ouspenski, I.,
Brinkley, B. R.,
and May, G. S.
(1998)
Chromosoma
107,
570-576[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Hudson, D. F.,
Fowler, K. J.,
Earle, E.,
Saffery, R.,
Kalitsis, P.,
Trowell, H.,
Hill, J.,
Wreford, N. G.,
de Kretser, D. M.,
Cancilla, M. R.,
Howman, E.,
Hii, L.,
Cutts, S. M.,
Irvine, D. V.,
and Choo, K. H. A.
(1998)
J. Cell Biol.
141,
309-319[Abstract/Free Full Text]
|
| 25.
|
Chen, R. H.,
Waters, J. C.,
Salmon, E. D.,
and Murray, A. W.
(1996)
Science
274,
242-246[Abstract/Free Full Text]
|
| 26.
|
Cutts, S. M.,
Fowler, K. J.,
Kile, B. T.,
Hii, L. L.,
O'Dowd, R. A.,
Hudson, D. F.,
Saffery, R.,
Kalitsis, P.,
Earle, E.,
and Choo, K. H. A.
(1999)
Hum. Mol. Genet.
8,
1145-1155[Abstract/Free Full Text]
|
| 27.
|
Mackay, A. M.,
Ainsztein, A. M.,
Eckley, D. M.,
and Earnshaw, W. C.
(1998)
J. Cell Biol.
140,
991-1002[Abstract/Free Full Text]
|
| 28.
|
Uren, A. G.,
Wong, L.,
Pakusch, M.,
Fowler, K. J.,
Burrows, F. J.,
Vaux, D. L.,
and Choo, K. H. A.
(2000)
Curr. Biol.
10,
1319-1328[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Yao, X.,
Abrieu, A.,
Zheng, Y.,
Sullivan, K. F.,
and Cleveland, D. W.
(2000)
Nat. Cell Biol.
2,
484-491[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Kalitsis, P.,
Earle, E.,
Fowler, K. J.,
and Choo, K. H. A.
(2000)
Genes Dev.
14,
2277-2282[Abstract/Free Full Text]
|
| 31.
|
Durkacz, B. W.,
Omidiji, O.,
Gray, D. A.,
and Shall, S.
(1980)
Nature
283,
593-596[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
de Murcia, G.,
Huletsky, A.,
Lamarre, D.,
Gaudreau, A.,
Pouyet, J.,
Daune, M.,
and Poirier, G. G.
(1986)
J. Biol. Chem.
261,
7011-7017[Abstract/Free Full Text]
|
| 33.
|
de Murcia, G.,
Huletsky, A.,
and Poirier, G. G.
(1988)
Biochem. Cell Biol.
66,
626-635[Medline]
[Order article via Infotrieve]
|
| 34.
|
Althaus, F. R.,
and Richter, C.
(1987)
ADP Ribosylation of Proteins
, Springer-Verlag, Berlin
|
| 35.
|
Shall, S.
(1994)
Mol. Cell. Biochem.
138,
71-75[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Uchida, K.,
and Miwa, M.
(1994)
Mol. Cell. Biochem.
138,
25-32[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Chen, Y. M.,
Shall, S.,
and O'Farrell, M.
(1994)
Eur. J. Biochem.
224,
135-142[Medline]
[Order article via Infotrieve]
|
| 38.
|
Malanga, M.,
Pleschke, J. M.,
Kleczkowska, H. E.,
and Althaus, F. R.
(1998)
J. Biol. Chem.
273,
11839-11843[Abstract/Free Full Text]
|
| 39.
|
Nozaki, T.,
Masutani, M.,
Akagawa, T.,
Sugimura, T.,
and Esumi, H.
(1994)
Biochem. Biophys. Res. Commun.
198,
45-51[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Oliver, F. J.,
Menissier-de Murcia, J.,
Nacci, C.,
Decker, P.,
Andriantsitohaina, R.,
Muller, S.,
de la Rubia, G.,
Stoclet, J. C.,
and de Murcia, G.
(1999)
EMBO J.
18,
4446-4454[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Simbulan-Rosenthal, C. M.,
Rosenthal, D. S.,
Boulares, A. H.,
Hickey, R. J.,
Malkas, L. H.,
Coll, J. M.,
and Smulson, M. E.
(1998)
Biochemistry
37,
9363-9370[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Okano, S.,
Kanno, S.,
Nakajima, S.,
and Yasui, A.
(2000)
J. Biol. Chem.
275,
32635-32641[Abstract/Free Full Text]
|
| 43.
|
Masson, M.,
Niedergang, C.,
Schreiber, V.,
Muller, S.,
Menissier-de Murcia, J.,
and de Murcia, G.
(1998)
Mol. Cell. Biol.
18,
3563-3571[Abstract/Free Full Text]
|
| 44.
|
de Murcia, G.,
and Menissier de Murcia, J.
(1994)
Trends Biochem. Sci.
19,
172-176[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
D'Amours, D.,
Desnoyers, S.,
D'Silva, I.,
and Poirier, G. G.
(1999)
Biochem. J.
342,
249-268[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Caldecott, K. W.,
Aoufouchi, S.,
Johnson, P.,
and Shall, S.
(1996)
Nucleic Acids Res.
24,
4387-4394[Abstract/Free Full Text]
|
| 47.
|
Burkle, A.
(2001)
Bioessays
23,
795-806[CrossRef][Medline]
[Order article via Infotrieve]
|
| 48.
|
Althaus, F. R.,
Kleczkowska, H. E.,
Malanga, M.,
Muntener, C. R.,
Pleschke, J. M.,
Ebner, M.,
and Auer, B.
(1999)
Mol. Cell. Biochem.
193,
5-11[CrossRef][Medline]
[Order article via Infotrieve]
|
| 49.
|
Wang, Z. Q.,
Stingl, L.,
Morrison, C.,
Jantsch, M.,
Los, M.,
Schulze-Osthoff, K.,
and Wagner, E. F.
(1997)
Genes Dev.
11,
2347-2358[Abstract/Free Full Text]
|
| 50.
|
Trucco, C.,
Oliver, F. J.,
de Murcia, G.,
and Menissier-de Murcia, J.
(1998)
Nucleic Acids Res.
26,
2644-2649[Abstract/Free Full Text]
|
| 51.
|
Simbulan-Rosenthal, C. M.,
Haddad, B. R.,
Rosenthal, D. S.,
Weaver, Z.,
Coleman, A.,
Luo, R.,
Young, H. M.,
Wang, Z. Q.,
Ried, T.,
and Smulson, M. E.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
13191-13196[Abstract/Free Full Text]
|
| 52.
|
Masutani, M.,
Nozaki, T.,
Nakamoto, K.,
Nakagama, H.,
Suzuki, H.,
Kusuoka, O.,
Tsutsumi, M.,
and Sugimura, T.
(2000)
Mutat. Res.
462,
159-166[CrossRef][Medline]
[Order article via Infotrieve]
|
| 53.
|
de Murcia, J. M.,
Niedergang, C.,
Trucco, C.,
Ricoul, M.,
Dutrillaux, B.,
Mark, M.,
Oliver, F. J.,
Masson, M.,
Dierich, A.,
LeMeur, M.,
Walztinger, C.,
Chambon, P.,
and de Murcia, G.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
7303-7307[Abstract/Free Full Text]
|
| 54.
|
d'Adda di Fagagna, F.,
Hande, M. P.,
Tong, W. M.,
Lansdorp, P. M.,
Wang, Z. Q.,
and Jackson, S. P.
(1999)
Nat. Genet.
23,
76-80[Medline]
[Order article via Infotrieve]
|
| 55.
|
Ame, J. C.,
Rolli, V.,
Schreiber, V.,
Niedergang, C.,
Apiou, F.,
Decker, P.,
Muller, S.,
Hoger, T.,
Menissier-de Murcia, J.,
and de Murcia, G.
(1999)
J. Biol. Chem.
274,
17860-17868[Abstract/Free Full Text]
|
| 56.
|
Johansson, M.
(1999)
Genomics
57,
442-445[CrossRef][Medline]
[Order article via Infotrieve]
|
| 57.
|
Jean, L.,
Risler, J. L.,
Nagase, T.,
Coulouarn, C.,
Nomura, N.,
and Salier, J. P.
(1999)
FEBS Lett.
446,
6-8[CrossRef][Medline]
[Order article via Infotrieve]
|
| 58.
|
Kaminker, P. G.,
Kim, S. H.,
Taylor, R. D.,
Zebarjadian, Y.,
Funk, W. D.,
Morin, G. B.,
Yaswen, P.,
and Campisi, J.
(2001)
J. Biol. Chem.
276,
35891-35899[Abstract/Free Full Text]
|
| 59.
|
Kickhoefer, V. A.,
Siva, A. C.,
Kedersha, N. L.,
Inman, E. M.,
Ruland, C.,
Streuli, M.,
and Rome, L. H.
(1999)
J. Cell Biol.
146,
917-928[Abstract/Free Full Text]
|
| 60.
|
Shieh, W. M.,
Ame, J. C.,
Wilson, M. V.,
Wang, Z. Q.,
Koh, D. W.,
Jacobson, M. K.,
and Jacobson, E. L.
(1998)
J. Biol. Chem.
273,
30069-30072[Abstract/Free Full Text]
|
| 61.
|
Smith, S.,
Giriat, I.,
Schmitt, A.,
and de Lange, T.
(1998)
Science
282,
1484-1487[Abstract/Free Full Text]
|
| 62.
|
Earle, E.,
Saxena, A.,
MacDonald, A.,
Hudson, D. F.,
Shaffer, L. G.,
Saffery, R.,
Cancilla, M. R.,
Cutts, S. M.,
Howman, E.,
and Choo, K. H. A.
(2000)
Hum. Mol. Genet.
9,
187-194[Abstract/Free Full Text]
|
| 63.
|
Saffery, R.,
Earle, E.,
Irvine, D. V.,
Kalitsis, P.,
and Choo, K. H. A.
(1999)
Chromosome Res.
7,
261-265[CrossRef][Medline]
[Order article via Infotrieve]
|
| 64.
|
Saffery, R.,
Irvine, D. V.,
Griffiths, B.,
Kalitsis, P.,
Wordeman, L.,
and Choo, K. H. A.
(2000)
Hum. Mol. Genet.
9,
175-185[Abstract/Free Full Text]
|
| 65.
|
Pleschke, J. M.,
Kleczkowska, H. E.,
Strohm, M.,
and Althaus, F. R.
(2000)
J. Biol. Chem.
275,
40974-40980[Abstract/Free Full Text]
|
| 66.
|
Martinez-Exposito, M. J.,
Kaplan, K. B.,
Copeland, J.,
and Sorger, P. K.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
8493-8498[Abstract/Free Full Text]
|
| 67.
|
Zeitlin, S. G.,
Shelby, R. D.,
and Sullivan, K. F.
(2001)
J. Cell Biol.
155,
1147-1158[Abstract/Free Full Text]
|
| 68.
|
Chan, G. K.,
Jablonski, S. A.,
Sudakin, V.,
Hittle, J. C.,
and Yen, T. J.
(1999)
J. Cell Biol.
146,
941-954[Abstract/Free Full Text]
|
| 69.
|
Daum, J. R.,
Tugendreich, S.,
Topper, L. M.,
Jorgensen, P. M.,
Hoog, C.,
Hieter, P.,
and Gorbsky, G. J.
(2000)
Curr. Biol.
10,
850-852
|
| 70.
|
Ishida, R.,
Takashima, R.,
Koujin, T.,
Shibata, M.,
Nozaki, N.,
Seto, M.,
Mori, H.,
Haraguchi, T.,
and Hiraoka, Y.
(2001)
Cell Struct. Funct.
26,
215-226[CrossRef][Medline]
[Order article via Infotrieve]
|
| 71.
|
Abrieu, A.,
Magnaghi-Jaulin, L.,
Kahana, J. A.,
Peter, M.,
Castro, A.,
Vigneron, S.,
Lorca, T.,
Cleveland, D. W.,
and Labbe, J. C.
(2001)
Cell
106,
83-93[CrossRef][Medline]
[Order article via Infotrieve]
|
| 72.
|
Adams, R. R.,
Wheatleya, S. P.,
Gouldsworthy, A. M.,
Kandels-Lewis, S. E.,
Carmena, M.,
Smythe, C.,
Gerloff, D. L.,
and Earnshaw, W. C.
(2000)
Curr. Biol.
10,
1075-1078[CrossRef][Medline]
[Order article via Infotrieve]
|
| 73.
|
Arnaud, L.,
Pines, J.,
and Nigg, E. A.
(1998)
Chromosoma
107,
424-429[CrossRef][Medline]
[Order article via Infotrieve]
|
| 74.
|
Jablonski, S. A.,
Chan, G. K.,
Cooke, C. A.,
Earnshaw, W. C.,
and Yen, T. J.
(1998)
Chromosoma
107,
386-396[CrossRef][Medline]
[Order article via Infotrieve]
|
| 75.
|
Ashar, H. R.,
James, L.,
Gray, K.,
Carr, D.,
Black, S.,
Armstrong, L.,
Bishop, W. R.,
and Kirschmeier, P.
(2000)
J. Biol. Chem.
275,
30451-30457[Abstract/Free Full Text]
|
| 76.
|
Page, A. M.,
and Hieter, P.
(1999)
Annu. Rev. Biochem.
68,
583-609[CrossRef][Medline]
[Order article via Infotrieve]
|
| 77.
|
Burkle, A.,
Grube, K.,
and Kupper, J. H.
(1992)
Exp. Clin. Immunogenet.
9,
230-240[Medline]
[Order article via Infotrieve]
|
| 78.
|
Herceg, Z.,
and Wang, Z. Q.
(2001)
Mutat. Res.
477,
97-110[Medline]
[Order article via Infotrieve]
|
| 79.
|
Jeggo, P. A.
(1998)
Curr. Biol.
8,
49-51
|
| 80.
|
Ziegler, M.,
and Oei, S. L.
(2001)
Bioessays
23,
543-548[CrossRef][Medline]
[Order article via Infotrieve]
|
| 81.
|
deMurcia, G.,
and Shall, S.
(2000)
From DNA Damage and Stress Signalling to Cell Death: Poly ADP Ribosylation Reactions
, Oxford University Press, New York
|
| 82.
|
Choo, K. H. A.
(2001)
Dev. Cell
1,
165-177[CrossRef][Medline]
[Order article via Infotrieve]
|
| 83.
|
Yoda, K.,
Ando, S.,
Morishita, S.,
Houmura, K.,
Hashimoto, K.,
Takeyasu, K.,
and Okazaki, T.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
7266-7271[Abstract/Free Full Text]
|
| 84.
|
Lo, A. W.,
Craig, J. M.,
Saffery, R.,
Kalitsis, P.,
Irvine, D. V.,
Earle, E.,
Magliano, D. J.,
and Choo, K. H. A.
(2001)
EMBO J.
20,
2087-2096[CrossRef][Medline]
[Order article via Infotrieve]
|
| 85.
|
du Sart, D.,
Cancilla, M. R.,
Earle, E.,
Mao, J. I.,
Saffery, R.,
Tainton, K. M.,
Kalitsis, P.,
Martyn, J.,
Barry, A. B.,
and Choo, K. H. A.
(1997)
Nat. Genet.
16,
144-153[CrossRef][Medline]
[Order article via Infotrieve]
|
| 86.
|
Van Hooser, A. A.,
Ouspenski, II,
Gregson, H. C.,
Starr, D. A.,
Yen, T. J.,
Goldberg, M. L.,
Yokomori, K.,
Earnshaw, W. C.,
Sullivan, K. F.,
and Brinkley, B. R.
(2001)
J. Cell Sci.
114,
3529-3542[Abstract/Free Full Text]
|
| 87.
|
Luger, K.,
Mader, A. W.,
Richmond, R. K.,
Sargent, D. F.,
and Richmond, T. J.
(1997)
Nature
389,
251-260[CrossRef][Medline]
[Order article via Infotrieve]
|
| 88.
|
Yoda, K.,
Ando, S.,
Okuda, A.,
Kikuchi, A.,
and Okazaki, T.
(1998)
Genes Cells
3,
533-548[Abstract]
|
| 89.
|
Kipling, D.,
and Warburton, P. E.
(1997)
Trends Genet.
13,
141-145[CrossRef][Medline]
[Order article via Infotrieve]
|
| 90.
|
Voullaire, L. E.,
Slater, H. R.,
Petrovic, V.,
and Choo, K. H. A.
(1993)
Am. J. Hum. Genet.
52,
1153-1163[Medline]
[Order article via Infotrieve]
|
| 91.
|
Irelan, J. T.,
Gutkin, G. I.,
and Clarke, L.
(2001)
Genetics
157,
1191-1203[Abstract/Free Full Text]
|
| 92.
|
Chang, W. J.,
and Alvarez-Gonzalez, R.
(2001)
J. Biol. Chem.
276,
47664-47670[Abstract/Free Full Text]
|
| 93.
|
Simbulan-Rosenthal, C. M.,
Rosenthal, D. S.,
Luo, R. B.,
Samara, R.,
Jung, M.,
Dritschilo, A.,
Spoonde, A.,
and Smulson, M. E.
(2001)
Neoplasia
3,
179-188[CrossRef][Medline]
[Order article via Infotrieve]
|
| 94.
|
Smith, S.
(2001)
Trends Biochem. Sci.
26,
174-179[CrossRef][Medline]
[Order article via Infotrieve]
|
| 95.
|
Poirier, G. G.,
de Murcia, G.,
Jongstra-Bilen, J.,
Niedergang, C.,
and Mandel, P.
(1982)
Proc. Natl. Acad. Sci. U. S. A.
79,
3423-3427[Abstract/Free Full Text]
|
| 96.
|
Burkle, A.
(1998)
Exp. Gerontol.
33,
519-523[CrossRef][Medline]
[Order article via Infotrieve]
|
| 97.
|
Jacobson, E. L.,
Giacomoni, P. U.,
Roberts, M. J.,
Wondrak, G. T.,
and Jacobson, M. K.
(2001)
J. Photochem. Photobiol. B
63,
141-147[CrossRef][Medline]
[Order article via Infotrieve]
|
| 98.
|
Amor, Y.,
Babiychuk, E.,
Inze, D.,
and Levine, A.
(1998)
FEBS Lett.
440,
1-7[CrossRef][Medline]
[Order article via Infotrieve]
|
| 99.
|
Hageman, G. J.,
Stierum, R. H.,
van Herwijnen, M. H.,
van der Veer, M. S.,
and Kleinjans, J. C.
(1998)
Nutr. Cancer
32,
113-120[Medline]
[Order article via Infotrieve]
|
| 100.
|
Love, S.
(1999)
Brain Pathol.
9,
119-131[Medline]
[Order article via Infotrieve]
|
| 101.
|
Szabo, C.,
and Dawson, V. L.
(1998)
Trends Pharmacol. Sci.
19,
287-298[CrossRef][Medline]
[Order article via Infotrieve]
|
| 102.
|
Taylor, S. S., Ha, E.,
and McKeon, F.
(1998)
J. Cell Biol.
142,
1-11[Abstract/Free Full Text]
|
| 103.
|
Fraschini, R.,
Beretta, A.,
Sironi, L.,
Musacchio, A.,
Lucchini, G.,
and Piatti, S.
(2001)
EMBO J.
20,
6648-6659[CrossRef][Medline]
[Order article via Infotrieve]
|
| 104.
|
Brady, D. M.,
and Hardwick, K. G.
(2000)
Curr. Biol.
10,
675-678[CrossRef][Medline]
[Order article via Infotrieve]
|
| 105.
|
Masutani, M.,
Nozaki, T.,
Nishiyama, E.,
Shimokawa, T.,
Tachi, Y.,
Suzuki, H.,
Nakagama, H.,
Wakabayashi, K.,
and Sugimura, T.
(1999)
Mol. Cell Biochem.
193,
149-152[CrossRef][Medline]
[Order article via Infotrieve]
|
| 106.
|
Shall, S.,
and de Murcia, G.
(2000)
Mutat. Res.
460,
1-15[Medline]
[Order article via Infotrieve]
|
| 107.
|
Tong, W. M.,
Cortes, U.,
and Wang, Z. Q.
(2001)
Biochim. Biophys. Acta
1552,
27-37[Medline]
[Order article via Infotrieve]
|
| 108.
|
Wang, Z. Q.,
Auer, B.,
Stingl, L.,
Berghammer, H.,
Haidacher, D.,
Schweiger, M.,
and Wagner, E. F.
(1995)
Genes Dev.
9,
509-520[Abstract/Free Full Text]
|